SELLAS Life Sciences (SLS) Return on Capital Employed (2020 - 2024)
SELLAS Life Sciences (SLS) has disclosed Return on Capital Employed for 7 consecutive years, with 3.21% as the latest value for Q3 2024.
- Quarterly Return on Capital Employed rose 2139.0% to 3.21% in Q3 2024 from the year-ago period, while the trailing twelve-month figure was 3.21% through Sep 2024, up 2139.0% year-over-year, with the annual reading at 245.9% for FY2023, 25109.0% up from the prior year.
- Return on Capital Employed for Q3 2024 was 3.21% at SELLAS Life Sciences, up from 4.5% in the prior quarter.
- The five-year high for Return on Capital Employed was 5.75% in Q4 2023, with the low at 40.73% in Q1 2024.
- Average Return on Capital Employed over 5 years is 5.81%, with a median of 3.02% recorded in 2022.
- Peak annual rise in Return on Capital Employed hit 2139bps in 2024, while the deepest fall reached -3690bps in 2024.
- Over 5 years, Return on Capital Employed stood at 0.85% in 2020, then dropped by -9bps to 0.93% in 2021, then tumbled by -466bps to 5.27% in 2022, then soared by 209bps to 5.75% in 2023, then crashed by -156bps to 3.21% in 2024.
- According to Business Quant data, Return on Capital Employed over the past three periods came in at 3.21%, 4.5%, and 40.73% for Q3 2024, Q2 2024, and Q1 2024 respectively.